Transphorm Q4 EPS $(0.13) Misses $(0.11) Estimate, Sales $3.20M Miss $4.67M Estimate
Portfolio Pulse from Benzinga Newsdesk
Transphorm (NASDAQ:TGAN) reported Q4 losses of $(0.13) per share, missing the analyst consensus estimate of $(0.11) by 18.18%. This is a 62.5% decrease from the same period last year. The company also reported quarterly sales of $3.20 million, missing the analyst consensus estimate of $4.67 million by 31.48%. This is a 35.05% decrease from the same period last year.
June 27, 2023 | 8:34 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Transphorm's Q4 earnings and sales missed estimates, with significant decreases from the same period last year.
Transphorm's Q4 earnings and sales missed analyst estimates, which is typically seen as a negative signal by the market. This, combined with the significant year-over-year decreases, could lead to a negative short-term impact on the stock price.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100